Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ALVO
#4562
Alvotech - Ordinary Shares
0.0
3
USD
-99.02%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-99.02%
Monthly Change
-98.98%
6 month change
-99.34%
Year Change
-99.60%
Previous Close
3.4
3
Open
0.0
3
Low
0.0
3
High
0.0
3
Volume
23
Markets
US Stock Market
Healthcare
ALVO
Open full chart
Full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
248.65 M
266.82 M
301.81 M
312.02 M
312.02 M
Valuation ratios
Enterprise value
2.42 B
3.02 B
3.94 B
1.43 B
1.04 B
Price to earnings ratio
—
—
—
—
—
Price to sales ratio
—
—
—
—
—
Price to cash flow ratio
—
—
—
—
—
Price to book ratio
—
—
—
—
—
Enterprise value to EBITDA ratio
—
—
—
—
—
Profitability ratios
Return on assets %
0.62
0.58
0.19
0.02
—
Return on equity %
0.91
0.59
0.56
0.1
—
Return on invested capital %
—
—
—
—
—
Gross margin %
347.66
98.68
18.47
7.38
—
Operating margin %
5 756.76
2.91
14.22
13.34
—
EBITDA margin %
—
—
—
—
—
Net margin %
8 534.06
4.52
47.35
4.76
—
Liquidity ratios
Quick ratio
0.95
0.46
1.69
1.16
—
Current ratio
1.38
0.75
2.35
1.89
—
Inventory turnover
0.9
2.2
1.83
1.35
—
Asset turnover
0.01
13.72
0.45
0.43
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
—
—
—
EBIT per share
—
—
—
—
—
EBITDA per share
—
—
—
—
—
Total debt per share
—
—
—
—
—
Cash per share
—
—
—
—
—
Net current asset value per share
—
—
—
—
—
Tangible book value per share
—
—
—
—
—
Working capital per share
—
—
—
—
—
Book value per share
—
—
—
—
—
News
Alvotech 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:ALVO) 2026-05-07
Alvotech (ALVO) Reports Q1 Loss, Lags Revenue Estimates
Johnson & Johnson: Why I See Downside Ahead (NYSE:JNJ)
Alvotech: Improving Fundamentals Signal Potential Bottom For This Biosimilar Player (ALVO)
Alvotech 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:ALVO) 2026-03-19
Royce Smaller-Companies Growth Fund FY 2025: What Worked… And What Didn’t
Alvotech stock hits 52-week low at 3.65 USD
Alvotech stock hits 52-week low at 3.89 USD
Alvotech stock hits 52-week low at $4.31 amid challenging year
Dr. Reddy's Q3 Earnings Match Estimates, Revenues Rise Y/Y
Alvotech: Why FDA Delays Don't Break The Bull Case (NASDAQ:ALVO)
ANIP vs. TEVA: Which Drug Stock Is the Better Buy Right Now?